{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-039387","form_type":"8-K","ticker":"KPTI","cik":"0001503802","company_name":"Karyopharm Therapeutics Inc.","filed_at":"2024-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.363956+00:00","generated_at":"2026-06-05T23:01:29.093047+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Karyopharm regains Nasdaq minimum bid price compliance","bullets":["Nasdaq confirmed Karyopharm regained compliance with Bid Price Rule on Feb 16, 2024.","Company met $1.00 minimum closing bid for 10 consecutive business days through Feb 15, 2024.","Non-compliance was first disclosed on Dec 12, 2023; this resolves the listing deficiency.","No effect on business operations or financial condition."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-039387","json":"https://secwatch.observer/filing/0001193125-24-039387.json","markdown":"https://secwatch.observer/filing/0001193125-24-039387.md","text":"https://secwatch.observer/filing/0001193125-24-039387.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1503802/000119312524039387/0001193125-24-039387-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1503802/000119312524039387/d774101d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T23:01:29.093047+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}